当前位置: X-MOL 学术Circulation › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Evolution of the Use of β-Blockers to Treat Heart Failure
Circulation ( IF 35.5 ) Pub Date : 2017-09-05 , DOI: 10.1161/circulationaha.117.029934
Finn Waagstein , John D. Rutherford

Finn Waagstein was born in Copenhagen in 1938. He graduated from Aarhus University Medical School in 1964. He received his cardiology training in the Sahlgrenska University Hospital at the University of Gothenburg, Sweden. He was appointed Associate Professor in 1980, and he assisted in establishing and directing the first Swedish heart transplant program. From 1990 he directed the heart failure and cardiomyopathy research programs. He is currently Professor of Cardiology and senior physician at Wallenberg Laboratory. In 2002, he was awarded the King Faisal International Prize for Medicine.


中文翻译:

使用β受体阻滞剂治疗心力衰竭的演变

Finn Waagstein于1938年出生于哥本哈根。他于1964年毕业于奥胡斯大学医学院。他在瑞典哥德堡大学的萨尔格伦斯卡大学医院接受了心脏病学培训。他于1980年被任命为副教授,他协助建立和指导了第一个瑞典心脏移植计划。从1990年开始,他负责心力衰竭和心肌病研究计划。他目前是Wallenberg实验室的心脏病学教授和高级医师。2002年,他被授予费萨尔国王国际医学奖。
更新日期:2017-09-06
down
wechat
bug